Pure Global

錄秘帕斯 G 異常凝血酶原-N 檢驗試劑 - Taiwan Registration b7760178990f96874b7436f4d8b5dddd

Access comprehensive regulatory information for 錄秘帕斯 G 異常凝血酶原-N 檢驗試劑 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b7760178990f96874b7436f4d8b5dddd and manufactured by Fujirebio Inc. Sagamihara Facility. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
b7760178990f96874b7436f4d8b5dddd
Registration Details
Taiwan FDA Registration: b7760178990f96874b7436f4d8b5dddd
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

錄秘帕斯 G 異常凝血酶原-N 檢驗試劑
Risk Class 2

Registration Details

b7760178990f96874b7436f4d8b5dddd

DHA05603624100

Company Information

Product Details

Quantitatively measured abnormal prothrombin (PIVKA-II) in human serum or plasma with the Phospas G system to assist in the diagnosis of hepatocellular carcinoma.

C Immunology and microbiology

C.6010 腫瘤相關抗原免疫試驗系統

QMS/QSD;; 輸入

Dates and Status

Dec 07, 2023

Dec 07, 2028